ASPI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ASP Isotopes Inc (ASPI) does not present a strong buy opportunity for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has shown significant revenue growth, its financials remain weak with negative net income, declining gross margins, and no clear valuation data. The technical indicators are neutral, and there are no strong trading signals or significant catalysts to justify immediate investment. Holding off for now is recommended.
The MACD is positive and expanding, suggesting mild bullish momentum. RSI is neutral at 58.779, and moving averages are converging, indicating no clear trend. Key support is at 5.04, and resistance is at 6.224. The stock has an 80% chance to decline by -0.85% in the next day but a 6.84% chance to rise in the next week.
The company recently signed a non-binding agreement with a large U.S. energy company, reflecting market optimism. Additionally, its CEO highlighted growth potential in stable isotopes and nuclear fuels, which aligns with increasing demand for advanced nuclear fuel production.
Halper Sadeh LLC is investigating potential breaches of fiduciary duties by company officers and directors. The gross margin has dropped significantly (-68% YoY), and the company remains unprofitable with negative EPS.
In Q3 2025, revenue increased by 349.53% YoY to $4,889,526, but net income remains negative at -$12,874,007, albeit improving by 77.05% YoY. EPS improved to -0.15 (up 25% YoY), but gross margin dropped significantly to 8.65% (-68% YoY).
No data on analyst ratings or price target changes is available.
